Pharmacy-based predictors of non-adherence, non-persistence and reinitiation of antihypertensive drugs among patients on oral diabetes drugs in the Netherlands

Abstract

BackgroundAdherence to antihypertensive drugs in patients with diabetes is important. To support adherence, attention should be paid to the dynamic process of implementation, persistence and reinitiation of these drugs. We assessed non-adherence, non-persistence and reinitiation patterns for antihypertensive drugs in patients on oral diabetes drugs and identified pharmacy-based predictors of these processes.MethodsWe conducted a cohort study in patients on oral diabetes drugs who initiated antihypertensive drugs between 1995–2015, as registered in the IADB.nl pharmacy database. Non-adherence was defined as a medication possession ratio < 80% and non-persistence as a gap > 180 days. We defined reinitiation as the dispensing of an antihypertensive drug within one year following discontinuation. We provide descriptive statistics for different time periods and applied logistic and Cox regressions to assess associations with sociodemographic and drug-related factors.ResultsOf 6,669 initiators, non-adherence rates in persistent patients decreased from 11.0% in the first year to 8.5% and 7.7% in the second and third years, respectively. Non-persistence rates decreased from 18.0% in the first year to 3.7% and 2.9% in the second and third years, respectively. Of the 1,201 patients who discontinued in the first year, 22.0% reinitiated treatment within one year. Non-adherence and non-persistence rates were lower in the more recent time period. Predictors of non-adherence were secondary prevention (OR: 1.45; 95% CI: 1.10–1.93) and diuretics as initial drug class (OR: 1.37; 95% CI: 1.08–1.74). Predictors of non-persistence were female gender (HR: 1.18; 95% CI: 1.05–1.32), older age (HR: 1.33; 95% CI: 1.08–1.63) and diuretics, beta-blocking agents or calcium channel blockers as initial drug class. Longer duration of persistence was a predictor of reinitiation.ConclusionsAdherence to antihypertensive drugs in patients on oral diabetes drugs has improved over time. The first year after initiation is the most crucial with regard to non-adherence and non-persistence, and the risk groups are different for both processes. Early non-persistence is a risk factor for not reinitiating treatment.

Reinitiation and Subsequent Discontinuation of Antiplatelet Treatment in Nonpersistent Older Patients with Peripheral Arterial Disease

“…Therefore, the physician’s explanation of the importance of lifelong administration of antiplatelet agents in PAD patients is of particular importance. In contrast to our results, Alfian et al [ 31 ] reported a longer duration of persistence to be a predictor of reinitiation. Their study was focused on the analysis of pharmacy-based predictors of nonadherence, nonpersistence, and reinitiation of antihypertensive drugs among patients on oral diabetes drugs.…”

An estimation of patients at potential risk for drug-induced sexual dysfunction using pharmacy dispensing data

“…Earlier, Holvast et al showed that, with pharmacy dispensing data in the Netherlands, 10% of antidepressant users (ATC: N06A) discontinued therapy within a comparable period (the first four weeks) ( 24 ). Also based on pharmacy dispensing data, Alfian et al reported that 18% of diabetes patients in the North of the Netherlands stopped their cardiovascular drug treatment (ATC: C03, C07, C08 and C09) within the first year ( 25 ). Compared with both studies, our analysis was more specific, focusing on spironolactone and antidepressants that are registered with >10% risk for sADRs.…”

Comparing the Sensitivities of Measures of Adherence to Antihypertensive Drugs Using Korean National Health Insurance Claims Data

“…[29][30][31] In addition, we defined the basecase for the minimum period of medication use, which was referred to how long medications were taken, as 90 days and set the observation period of 3 years in the current study. 32…”